MARK DYNE

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Protagenic Therapeutics, Inc.\new

Filing Date Source Excerpt
2009-05-26 Mark Dyne 47 Director
2010-10-25 Includes 3,892 shares of Common Stock held directly by Mr. Dyne, 2,738,359 shares of Common Stock held by MPLC Holdings, LLC of which Mr. Dyne is Manager, and 746,369 shares held by Europlay Capital Advisors, LLC, of which Mr. Dyne is the Chief Executive Officer and Chairman.

Data sourced from SEC filings. Last updated: 2026-03-05